BATS BZX Real-Time Price
As of 3:39pm ET
| +1.44 / +5.17%|
The 6 analysts offering 12-month price forecasts for Clovis Oncology Inc have a median target of 32.50, with a high estimate of 140.00 and a low estimate of 23.00. The median estimate represents a +11.04% increase from the last price of 29.27.
The current consensus among 6 polled investment analysts is to Hold stock in Clovis Oncology Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.